United Therapeutics Corp. (UTHR)
United Therapeutics Market Cap: 20.87B for Dec. 10, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Liquidia Corp. | 2.843B |
| Amgen, Inc. | 169.78B |
| Insmed, Inc. | 40.49B |
| Corcept Therapeutics, Inc. | 8.971B |
| Catalyst Pharmaceuticals, Inc. | 2.802B |
Market Cap Related Metrics
| PE Ratio | 18.37 |
| PS Ratio | 7.472 |
| PEG Ratio | 1.157 |
| Price to Book Value | 3.167 |
| Price to Free Cash Flow | 20.94 |
| Price | 484.73 |
| Earnings Yield | 5.44% |
| PEGY Ratio | 1.157 |
| Operating PE Ratio | 15.42 |
| Normalized PE Ratio | 18.17 |